4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-24-000083
Chief Business Officer gave up 661 shares (to pay taxes)
- Chief Business Officer acquired 2,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Boyle Scott N · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-16 | Exercise or conversion : show line 1 in the form | +2,250 | 54,580 | D | ||
| 2024-09-16 | Shares withheld for taxes : show line 2 in the form | −661 | $6.36 | $4,204 | 53,919 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-16 | Exercise or conversion : show line 3 in the form Performance Restricted Stock Units | −2,250 | 14,250 | D |
Loading xslF345X05/wk-form4_1726607550.xml…